Jiangsu Sihuan Bioengineering Co., Ltd (000518.SZ)
000518.SZ Stock Price Chart
Explore Jiangsu Sihuan Bioengineering Co., Ltd interactive price chart. Choose custom timeframes to analyze 000518.SZ price movements and trends.
000518.SZ Company Profile
Discover essential business fundamentals and corporate details for Jiangsu Sihuan Bioengineering Co., Ltd (000518.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
8 Sept 1993
Employees
282.00
Website
https://www.000518shsw.com/shswCEO
Yu Guo
Description
Jiangsu Sihuan Bioengineering Co., Ltd. engages in the pharmaceutical business in China. It offers Drewson, an anti-tumor biotherapeutic drug for the treatment of renal cancer, malignant melanoma, and cancerous thoracic and peritoneal effusion; and Xinde Lusheng for the treatment of kidney cancer, melanoma, lung cancer, gastric cancer, malignant lymphoma, breast cancer, ovarian tumor, bowel cancer, bladder cancer, head and neck tumor, leukemia and cancerous pleural effusion, etc. The company also provides Xin grain health, a recombinant human granulocyte colony stimulating factor injection; and Tourbo, a recombinant human erythropoietin injection for the treatment of anemia caused by renal insufficiency, including dialysis and non-dialysis patients. Jiangsu Sihuan Bioengineering Co., Ltd. was founded in 1992 and is headquartered in Jiangyin, China.
000518.SZ Financial Timeline
Browse a chronological timeline of Jiangsu Sihuan Bioengineering Co., Ltd corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 21 May 2025
EPS came in at -¥0.09 , while revenue for the quarter reached ¥47.52M .
Earnings released on 31 Mar 2025
EPS came in at -¥0.02 , while revenue for the quarter reached ¥43.84M .
Earnings released on 30 Sept 2024
EPS came in at -¥0.00 , while revenue for the quarter reached ¥50.19M .
Earnings released on 30 Jun 2024
EPS came in at -¥0.01 , while revenue for the quarter reached ¥49.41M .
Earnings released on 21 May 2024
EPS came in at -¥0.03 , while revenue for the quarter reached ¥55.48M .
Earnings released on 31 Mar 2024
EPS came in at -¥0.00 , while revenue for the quarter reached ¥56.40M .
Earnings released on 30 Sept 2023
EPS came in at -¥0.01 , while revenue for the quarter reached ¥58.52M .
Earnings released on 30 Jun 2023
EPS came in at -¥0.02 , while revenue for the quarter reached ¥64.40M .
Earnings released on 31 Mar 2023
EPS came in at -¥0.02 , while revenue for the quarter reached ¥57.01M .
Earnings released on 1 Jan 2023
EPS came in at -¥0.01 , while revenue for the quarter reached ¥73.52M .
Earnings released on 30 Sept 2022
EPS came in at -¥0.00 , while revenue for the quarter reached ¥78.23M .
Earnings released on 30 Jun 2022
EPS came in at -¥0.01 , while revenue for the quarter reached ¥68.04M .
Earnings released on 31 Mar 2022
EPS came in at -¥0.02 , while revenue for the quarter reached ¥50.36M .
Earnings released on 31 Dec 2021
EPS came in at -¥0.01 , while revenue for the quarter reached ¥114.75M .
Earnings released on 30 Sept 2021
EPS came in at ¥0.00 , while revenue for the quarter reached ¥86.46M .
Earnings released on 30 Jun 2021
EPS came in at -¥0.01 , while revenue for the quarter reached ¥78.86M .
Earnings released on 30 Apr 2021
EPS came in at ¥0.01 , while revenue for the quarter reached ¥150.98M .
Earnings released on 31 Mar 2021
EPS came in at -¥0.01 , while revenue for the quarter reached ¥70.88M .
Earnings released on 30 Sept 2020
EPS came in at ¥0.02 , while revenue for the quarter reached ¥117.84M .
000518.SZ Stock Performance
Access detailed 000518.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.